Xy­lo­Cor finds new back­ing to push re­gen­er­a­tive heart dis­ease gene ther­a­py deep­er in­to the clin­ic

Xy­lo­Cor Ther­a­peu­tics is one step clos­er to ac­com­plish­ing the tough task of de­liv­er­ing gene ther­a­pies straight in­to the heart for coro­nary artery dis­ease.

Three years …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.